Total Payments
$160.01
2018 Payments
$39.45
Companies
6
Transactions
13
Medicare Patients
4,046
Medicare Billing
$204,352
Payment Breakdown by Category
Food & Beverage$160.01 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $160.01 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $60.30 | 2 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $28.79 | 6 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $26.32 | 2 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $18.75 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.13 | 1 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $12.72 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $39.45 | 3 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($26.32) |
| 2017 | $120.56 | 10 | Allergan Inc. ($60.30) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: DIABETES | ||||||
| 05/09/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/03/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR ORAL (Drug), XIFAXANIBSD | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/28/2017 | Sunovion Pharmaceuticals Inc. | SEEBRI (Drug) | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: RESPIRATORY | ||||||
| 10/13/2017 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $47.04 | General |
| Category: DRY EYE | ||||||
| 10/11/2017 | Valeant Pharmaceuticals North America LLC | XIFAXANIBSD (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/15/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: RESPIRATORY | ||||||
| 05/23/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $3.14 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $1.45 | General |
| Category: RESPIRATORY | ||||||
| 04/13/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $5.45 | General |
| Category: RESPIRATORY | ||||||
| 03/23/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/15/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 907 | 1,295 | $226,071 | $55,922 |
| 2022 | 14 | 898 | 1,173 | $197,991 | $46,447 |
| 2021 | 16 | 1,005 | 1,391 | $215,797 | $52,000 |
| 2020 | 20 | 1,236 | 1,754 | $218,754 | $49,983 |
Total Patients
4,046
Total Services
5,613
Medicare Billing
$204,352
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 273 | 531 | $118,034 | $24,050 | 20.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 23 | 23 | $8,165 | $6,195 | 75.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 117 | $17,667 | $4,728 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 62 | 75 | $22,350 | $4,381 | 19.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 94 | 98 | $6,788 | $2,782 | 41.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 83 | 86 | $6,598 | $2,769 | 42.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 25 | 27 | $9,126 | $1,998 | 21.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 21 | 22 | $10,516 | $1,945 | 18.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 36 | 36 | $8,352 | $1,772 | 21.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 85 | 139 | $4,309 | $1,304 | 30.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 26 | 28 | $4,200 | $1,038 | 24.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 15 | 33 | $3,762 | $940.50 | 25.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $4,224 | $878.36 | 20.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 26 | 26 | $780.00 | $717.00 | 91.9% |
| 90471 | Administration of vaccine | Office | 2023 | 27 | 27 | $810.00 | $277.59 | 34.3% |
| 90472 | Administration of vaccine, each additional vaccine | Office | 2023 | 15 | 15 | $390.00 | $147.70 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 275 | 449 | $99,678 | $19,748 | 19.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 89 | 98 | $29,204 | $5,329 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 110 | $16,610 | $4,373 | 26.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 112 | 115 | $6,938 | $3,124 | 45.0% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 12 | 12 | $3,948 | $3,043 | 77.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 25 | 25 | $8,450 | $1,761 | 20.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 83 | 84 | $3,917 | $1,748 | 44.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 18 | 20 | $9,560 | $1,430 | 15.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 87 | 122 | $3,782 | $1,146 | 30.3% |
About Dr. Michael Cooper, D.O
Dr. Michael Cooper, D.O is a Family Medicine healthcare provider based in Claremore, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336109727.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Cooper, D.O has received a total of $160.01 in payments from pharmaceutical and medical device companies, with $39.45 received in 2018. These payments were reported across 13 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($160.01).
As a Medicare-enrolled provider, Cooper has provided services to 4,046 Medicare beneficiaries, totaling 5,613 services with total Medicare billing of $204,352. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Claremore, OK
- Active Since 03/28/2006
- Last Updated 02/17/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1336109727
Products in Payments
- RESTASIS (Drug) $47.04
- UTIBRON (Drug) $18.93
- XIFAXANIBSD (Drug) $18.75
- XIFAXAN (Drug) $14.56
- LINZESS (Drug) $13.26
- JARDIANCE (Drug) $13.13
- SOLIQUA (Drug) $12.72
- RELISTOR ORAL (Drug) $11.76
- SEEBRI (Drug) $6.72
- BROVANA (Drug) $3.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Claremore
Dr. Brent Hinkle, D.o, D.O
Family Medicine — Payments: $15,112
Family Medicine $15,112
Dr. Seth Nodine, Md, MD
Family Medicine — Payments: $14,679
Family Medicine $14,679
Dr. Andrew Sperling, D.o, D.O
Family Medicine — Payments: $14,639
Family Medicine $14,639
Dr. Jeffrey Williams, D.o, D.O
Family Medicine — Payments: $13,050
Family Medicine $13,050
Christen Greuel, D.o, D.O
Family Medicine — Payments: $6,854
Family Medicine $6,854
Ashley Bridges
Family Medicine — Payments: $5,694
Family Medicine $5,694